Betta Pharmaceuticals said on an interactive platform on July 4 that currently, the company is stepping up overseas business plans for ensartinib and actively exploring promotion models that meet local regulations and market needs to maximize drug accessibility and company benefits.

Zhitongcaijing · 3d ago
Betta Pharmaceuticals said on an interactive platform on July 4 that currently, the company is stepping up overseas business plans for ensartinib and actively exploring promotion models that meet local regulations and market needs to maximize drug accessibility and company benefits.